Phase II Randomized, Double-Blind Study of mFOLFIRINOX Plus Ramucirumab Versus mFOLFIRINOX Plus Placebo in Advanced Pancreatic Cancer Patients: Hoosier Cancer Research Network GI14-198
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2018
At a glance
- Drugs Ramucirumab (Primary) ; Fluorouracil; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 23 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 10 Aug 2016 Status changed from not yet recruiting to recruiting.
- 19 Jan 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2018, as reported by ClinicalTrials.gov.